Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2386 AL 2400

Telemedicine in Alzheimer's disease and other dementias: Where we are?

Angelopoulou E, Papageorgiou SG.

J Alzheimers Dis. 2025 Jan;103(1):3-18. doi: 10.1177/13872877241298295. Epub 2024 Dec 5.

"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective"

Aparajita A, Jain U, Srivastava P.

Neuroscience. 2025 Jan 26;565:499-518. doi: 10.1016/j.neuroscience.2024.11.078. Epub 2024 Dec 9.

Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies

Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A.

Ageing Res Rev. 2025 Feb;104:102639. doi: 10.1016/j.arr.2024.102639. Epub 2024 Dec 16.

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Canal-Garcia A, Branca RM, Francis PT, Ballard C, Winblad B, Lehtiö J, Nilsson P, Aarsland D, Pereira JB, Bereczki E.

Alzheimers Dement. 2025 Jan;21(1):e14375. doi: 10.1002/alz.14375. Epub 2024 Dec 23.

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis

Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J, Sheng X, Yuan L.

Pharmacol Res. 2025 Feb;212:107578. doi: 10.1016/j.phrs.2025.107578. Epub 2025 Jan 3.

The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer's Disease, and mild cognitive impairment

Yu Y, Shen H, Qin Q, Wang J, Nie Y, Wen L, Tang Y, Qu M.

Neuroscience. 2025 Mar 5;568:209-218. doi: 10.1016/j.neuroscience.2024.12.057. Epub 2025 Jan 10.

Is Charles Bonnet Syndrome a Harbinger of Neurocognitive Disorder With Lewy Bodies? A Clinical Conundrum

Kumari S, Nath S, Narasimha VL.

J Psychiatr Pract. 2025 Jan 1;31(1):49-52. doi: 10.1097/PRA.0000000000000828.

Two- and Three-Dimensional In Vitro Models of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Applications

Solana-Manrique C, Sánchez-Pérez AM, Paricio N, Muñoz-Descalzo S.

Int J Mol Sci. 2025 Jan 13;26(2):620. doi: 10.3390/ijms26020620.

Innate and adaptive immunity in neurodegenerative disease

Huang Y, Zhang G, Li S, Feng J, Zhang Z.

Cell Mol Life Sci. 2025 Feb 2;82(1):68. doi: 10.1007/s00018-024-05533-4.

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, Abu-Alghayth MH.

Ageing Res Rev. 2025 Mar;105:102684. doi: 10.1016/j.arr.2025.102684. Epub 2025 Feb 4.

Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer's disease and Parkinson's disease: Therapeutic avenue of Dual OXR Antagonist (DORA)

Panda SP, Sinha S, Kesharwani A, Kumar S, Singh M, Kondepudi GM, Samuel A, Sanghi AK, Thapliyal S, Chaubey KK, Guru A.

Biochem Pharmacol. 2025 Mar;233:116794. doi: 10.1016/j.bcp.2025.116794. Epub 2025 Feb 5.

Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's Diseases

Piccirillo S, Preziuso A, Serfilippi T, Cerqueni G, Terenzi V, Lariccia V, Magi S.

Curr Neuropharmacol. 2025;23(10):1169-1183. doi: 10.2174/011570159X345397241210103538.

Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders

Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, Singh G, Iqbal D, Padmapriya G, Kumar S, Kedia N, Verma R, Kumar R, Sinha A, Dheepak B, Abomughaid MM, Jha NK.

Mol Neurobiol. 2025 Jun;62(6):7975-7997. doi: 10.1007/s12035-024-04654-y. Epub 2025 Feb 17.

Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations

López-García P, Tejero-Ojeda MM, Vaquero ME, Carrión-Vázquez M.

Prog Neurobiol. 2025 Apr;247:102734. doi: 10.1016/j.pneurobio.2025.102734. Epub 2025 Feb 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias